Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

IARS anticorps (Middle Region)

IARS Reactivité: Humain WB Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN631746
  • Antigène Voir toutes IARS Anticorps
    IARS (Isoleucyl-tRNA Synthetase (IARS))
    Épitope
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Middle Region
    Reactivité
    • 15
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 10
    • 5
    Lapin
    Clonalité
    • 12
    • 3
    Polyclonal
    Conjugué
    • 15
    Cet anticorp IARS est non-conjugé
    Application
    • 14
    • 5
    • 4
    • 3
    • 2
    • 1
    • 1
    Western Blotting (WB)
    Specificité
    IARS antibody was raised against the middle region of IARS
    Purification
    Affinity purified
    Immunogène
    IARS antibody was raised using the middle region of IARS corresponding to a region with amino acids YEAAKVFGLRSRKLKLFLNETQTQEITEDIPVKTLNMKTVYVSVLPTTAD
    Top Product
    Discover our top product IARS Anticorps primaire
  • Indications d'application
    WB: 1 µg/mL
    Optimal conditions should be determined by the investigator.
    Commentaires

    IARS Blocking Peptide, catalog no. 33R-10078, is also available for use as a blocking control in assays to test for specificity of this IARS antibody

    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Reconstitution
    Lyophilized powder. Add distilled water for a 1 mg/mL concentration of IARS antibody in PBS
    Concentration
    Lot specific
    Buffer
    PBS
    Conseil sur la manipulation
    Avoid repeated freeze/thaw cycles.
    Dilute only prior to immediate use.
    Stock
    4 °C/-20 °C
    Stockage commentaire
    Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
  • Antigène
    IARS (Isoleucyl-tRNA Synthetase (IARS))
    Autre désignation
    IARS (IARS Produits)
    Synonymes
    anticorps fi46h05, anticorps zgc:63790, anticorps wu:fi46h05, anticorps K19E20.18, anticorps K19E20_18, anticorps ovule abortion 2, anticorps ECK0027, anticorps ilvS, anticorps JW0024, anticorps An08g06770, anticorps AO090012000505, anticorps 2510016L12Rik, anticorps AI327140, anticorps AU044614, anticorps E430001P04Rik, anticorps ILRS, anticorps Iarsl, anticorps IARS1, anticorps ILERS, anticorps IRS, anticorps PRO0785, anticorps isoleucyl-tRNA synthetase, anticorps tRNA synthetase class I (I, L, M and V) family protein, anticorps isoleucine--tRNA ligase, anticorps isoleucyl-tRNA synthetase, cytoplasmic, anticorps isoleucine-tRNA synthetase, anticorps iars, anticorps IARS, anticorps OVA2, anticorps ileS, anticorps MBAR_RS19160, anticorps Rmag_0340, anticorps ANI_1_964074, anticorps CHLREDRAFT_106327, anticorps EDI_049880, anticorps OE_RS08520, anticorps AOR_1_1912194, anticorps Iars
    Sujet
    Aminoacyl-tRNA synthetases catalyze the aminoacylation of tRNA by their cognate amino acid. Because of their central role in linking amino acids with nucleotide triplets contained in tRNAS, aminoacyl-tRNA synthetases are thought to be among the first proteins that appeared in evolution. Isoleucine-tRNA synthetase belongs to the class-I aminoacyl-tRNA synthetase family and has been identified as a target of autoantibodies in the autoimmune disease polymyositis/dermatomyositis. Two alternatively spliced variants have been isolated that represent alternate 5' UTRs.
    Poids moléculaire
    144 kDa (MW of target protein)
Vous êtes ici:
Support technique